Chemical Structure : Voxilaprevir
CAS No.: 1535212-07-7
Catalog No.: PC-61440Not For Human Use, Lab Use Only.
Voxilaprevir (GS-9857) is a potent HCV NS3/4A protease inhibitor that is used in combination with sofosbuvir and velpatasvir for treatment of HCV infection.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $358 | In stock | |
| 10 mg | $558 | In stock | |
| 25 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Voxilaprevir (GS-9857) is a potent HCV NS3/4A protease inhibitor that is used in combination with sofosbuvir and velpatasvir for treatment of HCV infection.
| M.Wt | 868.94 | |
| Formula | C40H52F4N6O9S | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
(33R,34S,35S,91R,92R,5S)-5-(tert-butyl)-N-((1R,2R)-2-(difluoromethyl)-1-(((1-methylcyclopropyl)sulfonyl)carbamoyl)cyclopropyl)-34-ethyl-14,14-difluoro-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphane-35-carboxamide |
|
1. Bourlière M, et al. N Engl J Med. 2017 Jun 1;376(22):2134-2146.
2. Gane EJ, et al. Gastroenterology. 2016 Nov;151(5):902-909.
3. Lawitz E, et al. Gastroenterology. 2016 Nov;151(5):893-901.e1.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright